Clinical Trial

Rutgers University Study of the Genetics of Kidney Disease

Study acronym: rugcc-kd
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to learn more about how genes impact the risk of kidney disease. Anyone 18 or older living in the US is eligible, and a diagnosis of kidney disease is NOT required. Study participation is online, and it takes about 20 minutes to complete health surveys and request a saliva collection kit sent through US mail. In return, study participants may opt to receive information about their genetic ancestry at no cost.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-10-14; most recent amendment 2026-04-23.
Trial Details
NCT Number NCT07217535
Lead Sponsor Rutgers, The State University of New Jersey
Collaborators: Regeneron Pharmaceuticals
Conditions Kidney Disease, Kidney Disease, Chronic, Kidney Disease, End-Stage, Kidney Diseases, Kidney Diseases, Chronic, Kidney Diseases,Cystic
Enrollment 50,000 participants
Start Date 2026-04-23
Primary Completion 2028-10-31 (estimated)
Study Completion 2028-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-24